scispace - formally typeset
P

Pedro Eduardo Fröehlich

Researcher at Universidade Federal do Rio Grande do Sul

Publications -  80
Citations -  1041

Pedro Eduardo Fröehlich is an academic researcher from Universidade Federal do Rio Grande do Sul. The author has contributed to research in topics: Dissolution testing & Pharmacokinetics. The author has an hindex of 18, co-authored 80 publications receiving 924 citations.

Papers
More filters
Journal ArticleDOI

Pharmacokinetic evaluation of doxorubicin plasma levels in normal and overweight patients with breast cancer and simulation of dose adjustment by different indexes of body mass.

TL;DR: A pilot study to verify if the usual dose adjustment based on body surface area (BSA) would be producing the same plasma concentration-time profiles in patients with normal (<25) and above normal (>25) body mass index (BMI).
Journal ArticleDOI

Determination of amphetamine-type stimulants in oral fluid by solid-phase microextraction and gas chromatography–mass spectrometry

TL;DR: The validated method can be easily automated and then used for screening and confirmation of amphetamine-type stimulants in drivers' oral fluid and the goodness-of-fit concerning the ordinary least squares model in the statistical inference of data has been tested through residual plotting and ANOVA.
Journal ArticleDOI

Development and validation of dissolution test for ritonavir soft gelatin capsules based on in vivo data

TL;DR: Both the HPLC method and the dissolution test are validated and could be used to evaluate the dissolution profile of ritonavir soft gelatin capsules.
Journal ArticleDOI

LC Method for Studies on the Stability of Lopinavir and Ritonavir in Soft Gelatin Capsules

TL;DR: In this article, a stability-indicating HPLC method was proposed to quantify ritonavir (RTV) and lopinavir (LPV) in soft gelatin capsules.
Journal ArticleDOI

High prevalence of hypovitaminosis D and secondary hyperparathyroidism in elders living in nonprofit homes in South Brazil.

TL;DR: Hypovitaminosis D and secondary hyperparathyroidism (SHP) are highly prevalent in elders living in old-age homes; however, SHP was independently related with age, 25(OH)D, GFR, and hydrochlorothiazide use.